Stay updated on ABSK-021 Safety in Solid Tumor Patients Clinical Trial
Sign up to get notified when there's something new on the ABSK-021 Safety in Solid Tumor Patients Clinical Trial page.

Latest updates to the ABSK-021 Safety in Solid Tumor Patients Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedExpanded list of trial locations across the United States and China (e.g., California, Colorado, Georgia, Texas, Beijing, Guangzhou, Hebei, Henan, Jiangsu, Liaoning, Shanghai, Shanxi, Sichuan, Zhejiang). Some previously listed location blocks were removed.SummaryDifference1%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.3.1 was removed, updating the page's revision tag. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check37 days agoChange DetectedThe page revision label was updated from v3.2.0 to v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check45 days agoChange DetectedRemoved the government funding status notice on the page, which previously warned about potential delays in updates and operating status. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check59 days agoChange DetectedNo significant updates to core study information are visible between the two screenshots.SummaryDifference0.3%

- Check88 days agoChange DetectedCore content updated with a government-operational notice and a new version tag (v3.2.0); a specific GRDC resource entry was removed (Tenosynovial giant cell tumor, diffuse type) and the version history shows a backward-incompatible removal from v3.1.0 to v3.2.0.SummaryDifference4%

Stay in the know with updates to ABSK-021 Safety in Solid Tumor Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ABSK-021 Safety in Solid Tumor Patients Clinical Trial page.